173 related articles for article (PubMed ID: 36891985)
1. Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism.
Kang HR; Dietrich EA; Huang PL; Lo-Ciganic WH; DeRemer CE; Park H
Clin Transl Sci; 2023 Jun; 16(6):946-954. PubMed ID: 36891985
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis.
Dawwas GK; Dietrich E; Smith SM; Davis K; Park H
Clin Ther; 2020 Sep; 42(9):e161-e176. PubMed ID: 32768247
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism.
Fang MC; Reynolds K; Fan D; Prasad PA; Sung SH; Portugal C; Garcia E; Go AS
JAMA Netw Open; 2023 Aug; 6(8):e2328033. PubMed ID: 37581888
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Safety of Extended Oral Anticoagulant Therapy in Patients with Venous Thromboembolism: A Retrospective Cohort Study.
Kang HR; Lo-Ciganic WH; DeRemer CE; Dietrich EA; Huang PL; Park H
Clin Pharmacol Ther; 2022 Jul; 112(1):133-145. PubMed ID: 35420702
[TBL] [Abstract][Full Text] [Related]
5. Trajectories of Oral Anticoagulation Adherence and Associated Clinical Outcomes During Long-Term Anticoagulation Among Medicare Beneficiaries With Venous Thromboembolism.
Park H; Jones BL; Huang PL; Kang HR; Dietrich EA; DeRemer CE; Lo-Ciganic WH
Ann Pharmacother; 2023 Dec; 57(12):1349-1360. PubMed ID: 36999519
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
8. Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism.
Zakai NA; Walker RF; MacLehose RF; Adam TJ; Alonso A; Lutsey PL
J Thromb Haemost; 2018 Dec; 16(12):2403-2412. PubMed ID: 30240508
[TBL] [Abstract][Full Text] [Related]
9. Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism.
Pawar A; Gagne JJ; Gopalakrishnan C; Iyer G; Tesfaye H; Brill G; Chin K; Bykov K
JAMA; 2022 Mar; 327(11):1051-1060. PubMed ID: 35289881
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism.
Dawwas GK; Smith SM; Dietrich E; Lo-Ciganic WH; Park H
Am J Health Syst Pharm; 2020 Jan; 77(3):188-195. PubMed ID: 31974557
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism.
Park H; Kang HR; Huang PL; Lo-Ciganic WH; DeRemer CE; Wilson D; Dietrich EA
Clin Transl Sci; 2023 Jan; 16(1):128-139. PubMed ID: 36200137
[TBL] [Abstract][Full Text] [Related]
12. Trajectories of adherence to extended treatment with direct oral anticoagulants and risks of recurrent venous thromboembolism and major bleeding.
Kang HR; Jones BL; Lo-Ciganic WH; DeRemer CE; Dietrich EA; Huang PL; Wilson DL; Park H
J Manag Care Spec Pharm; 2023 Nov; 29(11):1219-1230. PubMed ID: 37889866
[No Abstract] [Full Text] [Related]
13. Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism.
Coons JC; Albert L; Bejjani A; Iasella CJ
Pharmacotherapy; 2020 Mar; 40(3):204-210. PubMed ID: 31968126
[TBL] [Abstract][Full Text] [Related]
14. Comparative Safety and Effectiveness of Direct Oral Anticoagulants and Warfarin during Chemotherapy in Cancer Patients with Venous Thromboembolism Aged 75 Years or Older: A Nationwide Inpatient Database Study.
Iwai C; Jo T; Konishi T; Kumazawa R; Matsui H; Fushimi K; Yasunaga H
Gerontology; 2023; 69(5):561-570. PubMed ID: 36502790
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of oral anticoagulants in patients with sickle cell disease and venous thromboembolism: a retrospective cohort study.
Roberts MZ; Gaskill GE; Kanter-Washko J; Kyle TR; Jones BC; Bohm NM
J Thromb Thrombolysis; 2018 May; 45(4):512-515. PubMed ID: 29556958
[TBL] [Abstract][Full Text] [Related]
16. DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network.
Martin KA; Lancki N; Li C; Eyster ME; Sanfilippo K; Woller IA; Woller SC; Kreuziger LB; Rosovsky RP
J Thromb Thrombolysis; 2023 May; 55(4):685-690. PubMed ID: 36757644
[TBL] [Abstract][Full Text] [Related]
17. Transition of management strategies and long-term outcomes in cancer-associated venous thromboembolism from the warfarin era to the direct oral anticoagulant era.
Chatani R; Yamashita Y; Morimoto T; Kaneda K; Mushiake K; Kadota K; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Kimura T;
Eur J Intern Med; 2024 May; 123():72-80. PubMed ID: 38278660
[TBL] [Abstract][Full Text] [Related]
18. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Safety of Direct Oral Anticoagulants vs. Warfarin and Recurrence After Discontinuation in Patients With Acute Venous Thromboembolism in the Real World.
Hara N; Lee T; Nozato T; Terui Matsuyama M; Okata S; Nagase M; Mitsui K; Nitta G; Watanabe K; Miyazaki R; Nagamine S; Kaneko M; Nakamura T; Nagata Y; Miyamoto T; Obayashi T; Ashikaga T
Circ J; 2022 May; 86(6):923-933. PubMed ID: 34645732
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of direct oral anticoagulants following ultrasound-assisted catheter directed thrombolysis for venous thromboembolism.
Kelley D; Wright L; Ohman K; Ferreira J
J Thromb Thrombolysis; 2018 Jul; 46(1):58-61. PubMed ID: 29797208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]